Brett A. Grimaud insider trades
Open-market stock purchases and sales by Brett A. Grimaud, SVP, GEN COUNSEL AND SECRETARY at Theravance Biopharma, Inc, from SEC Form 4 filings since Feb 20, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | — |
| Aug 20, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $135K |
| May 20, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $146K |
| Apr 1, 2026 | TBPH Theravance Biopharma, Inc | Bought (not open market) | — |
| Feb 20, 2026 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $410K |
| Nov 20, 2025 | TBPH Theravance Biopharma, Inc | Sold (not open market) | $341K |
Companies traded
- TBPH Theravance Biopharma, Inc: other filings, last Sep 23, 2026